KDLY 📈 Kindly MD Common Stock - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
KDLY: Prescription Medicine, Behavioral Services, Therapy Sessions
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah. Web URL: https://kindlymd.com
Additional Sources for KDLY Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
KDLY Stock Overview
Market Cap in USD | 8m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2024-05-31 |
KDLY Stock Ratings
Growth 5y | -69.9% |
Fundamental | -76.8% |
Dividend | - |
Rel. Strength Industry | -1847 |
Analysts | - |
Fair Price Momentum | 0.89 USD |
Fair Price DCF | - |
KDLY Dividends
No Dividends PaidKDLY Growth Ratios
Growth Correlation 3m | 14.6% |
Growth Correlation 12m | -79.5% |
Growth Correlation 5y | -79.5% |
CAGR 5y | -62.91% |
CAGR/Mean DD 5y | -1.33 |
Sharpe Ratio 12m | -0.30 |
Alpha | -73.32 |
Beta | 0.27 |
Volatility | 140.56% |
Current Volume | 32.1k |
Average Volume 20d | 1043.6k |
What is the price of KDLY stocks?
As of December 22, 2024, the stock is trading at USD 1.12 with a total of 32,100 shares traded.
Over the past week, the price has changed by -13.85%, over one month by +23.08%, over three months by -6.67% and over the past year by -62.91%.
As of December 22, 2024, the stock is trading at USD 1.12 with a total of 32,100 shares traded.
Over the past week, the price has changed by -13.85%, over one month by +23.08%, over three months by -6.67% and over the past year by -62.91%.
Is Kindly MD Common Stock a good stock to buy?
No, based on ValueRay Fundamental Analyses, Kindly MD Common Stock (NASDAQ:KDLY) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -76.77 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KDLY as of December 2024 is 0.89. This means that KDLY is currently overvalued and has a potential downside of -20.54%.
No, based on ValueRay Fundamental Analyses, Kindly MD Common Stock (NASDAQ:KDLY) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -76.77 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KDLY as of December 2024 is 0.89. This means that KDLY is currently overvalued and has a potential downside of -20.54%.
Is KDLY a buy, sell or hold?
Kindly MD Common Stock has no consensus analysts rating.
Kindly MD Common Stock has no consensus analysts rating.
What are the forecast for KDLY stock price target?
According to ValueRays Forecast Model, KDLY Kindly MD Common Stock will be worth about 1 in December 2025. The stock is currently trading at 1.12. This means that the stock has a potential downside of -14.29%.
According to ValueRays Forecast Model, KDLY Kindly MD Common Stock will be worth about 1 in December 2025. The stock is currently trading at 1.12. This means that the stock has a potential downside of -14.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1 | -14.3% |